Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Gastric Cancer

Free Subscription Articles published in Eur J Surg Oncol Retrieve available abstracts of 182 articles: HTML format

Single Articles

August 2026
1. DE SOUZA FILHO O, Rondinelli R, Accetta AC, Albagli R, et al
   Repeated normothermic intraperitoneal paclitaxel perfusion via videolaparoscopy (RIPPENC-VLP) combined with CAPOX for gastric cancer with positive cytology or limited peritoneal metastasis: A prospective phase II study.
   Eur J Surg Oncol. 2026;52:112100.
   PubMed     Abstract available
   
   
   
2. POLKOWSKI WP, Wyrwicz LS
   Is uniform D2 still biologically optimal in gastric cancer? Lymphadenectomy in the immunotherapy era.
   Eur J Surg Oncol. 2026;52:112097.
   PubMed     Abstract available
   
   
   
3. POMORTSEV BA, Dalgatov KD, Baziyan YK, Saygin NV, et al
   Laparoscopic versus open total gastrectomy for gastric cancer: A four-year single-center cohort with propensity score matching and risk factor analysis.
   Eur J Surg Oncol. 2026;52:112074.
   PubMed     Abstract available
   
   
   
4. POLKOWSKI WP
   Beyond margin length: Integrating tumour biology into the extent of gastrectomy.
   Eur J Surg Oncol. 2026;52:111901.
   PubMed     Abstract available
   
   
   July 2026
5. PEHLEVAN OZEL H, Acehan F, Yilmaz Y, Okay ND, et al
   Time-dependent prognostic performance of nodal metrics after curative surgery for gastric cancer.
   Eur J Surg Oncol. 2026;52:112040.
   PubMed     Abstract available
   
   
   
6. CAO M, Li YL, Liu YQ, Li JZ, et al
   Morphological CT signs of Epstein-Barr virus-associated locally advanced gastric cancer: a radiological-pathological comparison study.
   Eur J Surg Oncol. 2026;52:112034.
   PubMed     Abstract available
   
   
   
7. CHEN S, Ding P, Guo H, Gao K, et al
   Temporal dynamics and spatial patterns of recurrence after curative gastrectomy for gastric cancer: A multicenter hazard function analysis of 3,278 patients.
   Eur J Surg Oncol. 2026;52:112000.
   PubMed     Abstract available
   
   
   
8. COLAKOGLU MK, Piskin E, Oter V, Guven A, et al
   Corrigendum to "Role of staging laparoscopy in gastric cancer management: Evaluation of occult disease and its influence on clinical decision making" [Eur J Surg Oncol 52 (2026) 111847].
   Eur J Surg Oncol. 2026;52:111989.
   PubMed    
   
   
   
9. CAI Z, Chen J, Xu Z, Lin H, et al
   Laparoscopic versus open surgery for locally advanced gastric gastrointestinal stromal tumors following neoadjuvant imatinib therapy: a multicenter propensity-weighted cohort study.
   Eur J Surg Oncol. 2026;52:111868.
   PubMed     Abstract available
   
   
   June 2026
10. SIAM B, Orgad R, Abbas M, Catzman NL, et al
    Rethinking perioperative chemotherapy in older adults with gastric cancer: a retrospective cohort study.
    Eur J Surg Oncol. 2026;52:111985.
    PubMed     Abstract available
    
    
    
11. LU X, Cui X, Chen H, Zhang J, et al
    Association of body composition parameters with pathological response to neoadjuvant immunochemotherapy in locally advanced gastric cancer.
    Eur J Surg Oncol. 2026;52:111973.
    PubMed     Abstract available
    
    
    
12. SANTOS LL, Finamore AC, Gisbertz S, Romario UF, et al
    Bridging prediction and reality: AI-based external validation of predictive models for lymph node metastasis in gastric cancer.
    Eur J Surg Oncol. 2026;52:111928.
    PubMed     Abstract available
    
    
    
13. BEN-ISHAY O, Harbi A, Gilshtein H
    Clinical characteristics and surgical management of adult gastric inflammatory myofibroblastic tumors: A systematic review and pooled individual patient data analysis.
    Eur J Surg Oncol. 2026;52:111817.
    PubMed     Abstract available
    
    
    May 2026
14. YOO J, Seo DH, Seong BO, Yook JH, et al
    Long-term outcomes of total versus distal gastrectomy in the older population with early gastric cancer: A propensity score-matched analysis.
    Eur J Surg Oncol. 2026;52:111916.
    PubMed     Abstract available
    
    
    
15. KAUR H, Silva TN, Wright JA, Woods SL, et al
    International practice patterns and perceptions of pressurised intraperitoneal aerosol chemotherapy for management of gastric cancer: A global clinician survey.
    Eur J Surg Oncol. 2026;52:111872.
    PubMed     Abstract available
    
    
    
16. CARBONE L, Cho YS, Kang MK, Park K, et al
    Robotic-assisted gastrectomy for 700 gastric cancer patients: A comparative analysis between specialized centers in Italy and Korea.
    Eur J Surg Oncol. 2026;52:111865.
    PubMed     Abstract available
    
    
    
17. XIAO GL, Huang ZN, Wang Y, Wu DZ, et al
    CT assessment of body composition and liver fat fraction predicts prognosis in gastric cancer.
    Eur J Surg Oncol. 2026;52:111855.
    PubMed     Abstract available
    
    
    
18. LI J, Liu L, Wu D, Wang H, et al
    Comparative survival in gastric cancer: Mucosa-confined with extensive nodal metastases versus serosal invasion without nodal spread.
    Eur J Surg Oncol. 2026;52:111857.
    PubMed     Abstract available
    
    
    
19. XU H, Hu Y, Yu J, Han X, et al
    Influence of body composition on short- and long-term clinical outcomes in patients undergoing laparoscopic gastrectomy.
    Eur J Surg Oncol. 2026;52:111786.
    PubMed     Abstract available
    
    
    April 2026
20. COLAKOGLU MK, Piskin E, Oter V, Guven A, et al
    Role of staging laparoscopy in gastric cancer management: Evaluation of occult disease and its influence on clinical decision making.
    Eur J Surg Oncol. 2026;52:111847.
    PubMed     Abstract available
    
    
    
21. HUANG ZN, Zhang HX, Chen F, Liu ZW, et al
    Integrating multi-omics data for enhanced prognosis prediction in gastric cancer post-neoadjuvant therapy.
    Eur J Surg Oncol. 2026;52:111837.
    PubMed     Abstract available
    
    
    March 2026
22. LAI B, Xiong Z, Zhong B, Chen S, et al
    Neoadjuvant chemotherapy for Lauren diffuse-type gastric cancer: Is it necessary?
    Eur J Surg Oncol. 2026;52:111767.
    PubMed     Abstract available
    
    
    
23. CHEN X, Zeng W, Li S, Wu Y, et al
    Latent category analysis of psychosocial characteristics of gastric cancer patients: an association study with quality of life and survival prognosis.
    Eur J Surg Oncol. 2026;52:111740.
    PubMed     Abstract available
    
    
    February 2026
24. RI M, Ohashi M, Hayami M, Irino T, et al
    Unexpected proximal tumor extension as a predictor of poor survival after distal gastrectomy for locally advanced gastric cancer.
    Eur J Surg Oncol. 2026;52:111513.
    PubMed     Abstract available
    
    
    
25. LI BL, Tu RH, Zhong Q, Suo WH, et al
    Modified gastric cancer ypTNM staging based on optimized lymph node staging: A large-sample, international multicenter study.
    Eur J Surg Oncol. 2026;52:111501.
    PubMed     Abstract available
    
    
    
26. CASELLA F, Geroin C, Meloni F, Bencivenga M, et al
    Enhanced recovery after surgery for gastric cancer with HIPEC: feasibility and outcomes in a complex setting.
    Eur J Surg Oncol. 2026;52:111483.
    PubMed     Abstract available
    
    
    
27. LIU C, Huang H, Liu J, Cao C, et al
    Effect of whole-course nutrition management on skeletal muscle mass in patients with gastric cancer undergoing neoadjuvant treatment.
    Eur J Surg Oncol. 2026;52:111463.
    PubMed     Abstract available
    
    
    
28. ERNUDD I, Mattsson F, Leijonmarck W, Sonden A, et al
    In-hospital complications after gastrectomy in relation to long-term survival in gastric adenocarcinoma: a population-based cohort study.
    Eur J Surg Oncol. 2026;52:111367.
    PubMed     Abstract available
    
    
    
29. ZHANG F, Yan Y, Li B, Wang Y, et al
    Comparative short-term outcomes of peri-operative immunotherapy and targeted therapy for gastric and gastroesophageal junction adenocarcinoma: a systematic review and network meta-analysis.
    Eur J Surg Oncol. 2026;52:111311.
    PubMed     Abstract available
    
    
    January 2026
30. ZHANG B, Wang Y, Yu B, Shan F, et al
    Appropriate number of retrieved lymph nodes is sufficient for node-negative patients with gastric cancer.
    Eur J Surg Oncol. 2026;52:111455.
    PubMed     Abstract available
    
    
    
31. WANG X, Wu T, Zhang X, Jin P, et al
    Optimal artificial intelligence model based on gastrointestinal filling contrast-enhanced ultrasound: Risk stratification of gastric gastrointestinal stromal tumors.
    Eur J Surg Oncol. 2026;52:111190.
    PubMed     Abstract available
    
    
    
32. CAO Y, Jin T, Chen Z, Du E, et al
    The association between pathological complete response and prognosis of gastric or adenocarcinoma of esophagogastric junction cancer following neoadjuvant chemotherapy: A meta-analysis.
    Eur J Surg Oncol. 2026;52:110528.
    PubMed     Abstract available
    
    
    December 2025
33. MATSUMOTO Y, Terashima M, Koseki Y, Furukawa K, et al
    Efficacy of D2 plus lymph node dissection for gastric cancer.
    Eur J Surg Oncol. 2025;52:111361.
    PubMed     Abstract available
    
    
    
34. HE QC, Huang ZN, Ma YB, Zheng CY, et al
    Identifying chemotherapy benefits in high-risk patients with stage IB gastric cancer based on recurrence prediction value: A multicenter retrospective study.
    Eur J Surg Oncol. 2025;52:111352.
    PubMed     Abstract available
    
    
    
35. LI J, Lin X, Yin H, Bei T, et al
    Corrigendum to "Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation study" [Eur. J. Surg. Oncol. 51 (2025) 110548].
    Eur J Surg Oncol. 2025;52:111336.
    PubMed    
    
    
    
36. XU R, Li Y, Zhao H, Wang Z, et al
    Treating a single tumor deposits as two lymph node metastases can improve the accuracy of gastric cancer prognosis assessment.
    Eur J Surg Oncol. 2025;52:111351.
    PubMed     Abstract available
    
    
    
37. BARTIN MK, Dogan I, Aslan F
    Surgical treatment in synchronous oesophageal cancers - A systematic review on survival outcomes.
    Eur J Surg Oncol. 2025;51:110480.
    PubMed     Abstract available
    
    
    
38. VELAYUDHAM GK, Shankar AS, Fox SJ, Bundred J, et al
    Impact of readmission location on survival after oesophagectomy and gastrectomy.
    Eur J Surg Oncol. 2025;51:110470.
    PubMed     Abstract available
    
    
    November 2025
39. SALOBIR J, Sever P, Birk M, Zagar T, et al
    Gastric cancer surgery in high volume university medical centers influences long-term survival.
    Eur J Surg Oncol. 2025;52:111312.
    PubMed     Abstract available
    
    
    
40. BAKHTIAR M, Razi S, Ahmed R, Mahnoor M, et al
    Efficacy and safety of intraperitoneal paclitaxel-based regimens in patients with gastric cancer and peritoneal metastasis: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;52:111299.
    PubMed     Abstract available
    
    
    
41. WANG H, Zhang H, Ma X, Bai Y, et al
    Application of machine learning algorithms and establishment of a web calculator in predicting distant metastasis of T2-T4 gastric cancer.
    Eur J Surg Oncol. 2025;52:111170.
    PubMed     Abstract available
    
    
    
42. LIU K, Yin K, Ma Y, Xia R, et al
    Clinicopathological features and survival differences between G/GEJ-CSC and GAC: A Propensity score-matched, large-scale cross-population retrospective study.
    Eur J Surg Oncol. 2025;51:110444.
    PubMed     Abstract available
    
    
    October 2025
43. LI J, Lin X, Yin H, Bei T, et al
    Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation study.
    Eur J Surg Oncol. 2025;51:110548.
    PubMed     Abstract available
    
    
    
44. LV C, Tong L, Lu J, Xu B, et al
    Postoperative recurrence patterns and prognostic determinants in early-onset early-stage gastric cancer: A multicenter retrospective real-world study.
    Eur J Surg Oncol. 2025;51:110544.
    PubMed     Abstract available
    
    
    
45. REN M, Chu Y, Han R, Chen Y, et al
    Risk factors for lymph node metastasis and survival: Toward better endoscopic selection in ulcerative versus nonulcerative early gastric cancer.
    Eur J Surg Oncol. 2025;51:110497.
    PubMed     Abstract available
    
    
    
46. CASTAGNA A, Ramouz A, Trinidad-Gutierrez I, Brindl N, et al
    Underreporting of molecular targets in surgically treated patients with peritoneal metastasis of gastric cancer.
    Eur J Surg Oncol. 2025;51:110502.
    PubMed     Abstract available
    
    
    
47. FERNANDES MHF, Valerio-Alves AP, Colares RA, de Franca Xavier JV, et al
    Indocyanine green-guided lymphadenectomy in gastric cancer after neoadjuvant chemotherapy: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:110499.
    PubMed     Abstract available
    
    
    
48. BORDEOS LN, Kim KY, Hwang J, Park SH, et al
    Safety and feasibility of subtotal resection of the remnant stomach for remnant gastric cancer: A propensity score matching analysis compared with completion total gastrectomy.
    Eur J Surg Oncol. 2025;51:110493.
    PubMed     Abstract available
    
    
    
49. AZIZI E, Okumura Y, Sunde B, Lindblad M, et al
    Pain management after minimally invasive gastrectomy: do we need epidural analgesia?
    Eur J Surg Oncol. 2025;51:110232.
    PubMed     Abstract available
    
    
    September 2025
50. PAN S, Zhu W, Zhang Y, Zhang R, et al
    Contour-like model for precision risk stratification in gastric cancer patients underwent neoadjuvant therapy: A multicenter retrospective study.
    Eur J Surg Oncol. 2025;51:110455.
    PubMed     Abstract available
    
    
    
51. ZHU D, Fang Z, Yang T, Lu Y, et al
    Influence of lymphadenectomy extent on the efficacy of immunotherapy in recurrent gastric cancer patients.
    Eur J Surg Oncol. 2025;51:110454.
    PubMed     Abstract available
    
    
    
52. ZHENG CY, Huang XL, Wu J, Qiu XT, et al
    Prognostic impact of myopenia and establishment of a nomogram for predicting survival following radical gastrectomy in patients with gastric cancer: A multicenter study.
    Eur J Surg Oncol. 2025;51:110450.
    PubMed     Abstract available
    
    
    
53. ZHANG H, Tao S, Luo Y, Lu M, et al
    Impact of nutrition, comorbidity and complication on long term survival in gastric cancer following laparoscopic radical gastrectomy: A 10-year cohort study.
    Eur J Surg Oncol. 2025;51:110442.
    PubMed     Abstract available
    
    
    
54. WANG Y, Liu X, Zhang X, Fan P, et al
    Impact of sarcopenic obesity on postoperative complications and long-term survival in patients with gastric cancer.
    Eur J Surg Oncol. 2025;51:110437.
    PubMed     Abstract available
    
    
    August 2025
55. TANG X, Wang X, Man C, Zhang S, et al
    The role of gut microbiota in the perioperative management of gastric cancer and intervention methods: A systematic review.
    Eur J Surg Oncol. 2025;51:110343.
    PubMed     Abstract available
    
    
    
56. TIAN Z, Zhang Y, Cheng Y, Wang D, et al
    Long-term muscle-sparing benefits of proximal gastrectomy in elderly patients with upper-third early gastric cancer: A propensity score-matched analysis.
    Eur J Surg Oncol. 2025;51:110373.
    PubMed     Abstract available
    
    
    
57. YEN HH, Lin YJ, Huang CC, Yeh CC, et al
    Oncological and functional outcomes of proximal versus total gastrectomy for advanced proximal gastric cancer: A propensity score-matched study.
    Eur J Surg Oncol. 2025;51:110370.
    PubMed     Abstract available
    
    
    
58. ZHANG HX, Huang ZN, Zhang XQ, Tang YH, et al
    Enhancing prognostic accuracy in gastric cancer: The TNrrM staging system versus the AJCC TNM system.
    Eur J Surg Oncol. 2025;51:110362.
    PubMed     Abstract available
    
    
    
59. HWANG J, Moon J, Kim KY, Park SH, et al
    Enhanced recovery and comparable long-term outcomes in reduced-port robotic distal gastrectomy versus conventional laparoscopic distal gastrectomy: A propensity score-matched analysis of single-center experience.
    Eur J Surg Oncol. 2025;51:110137.
    PubMed     Abstract available
    
    
    
60. BENARD F, Marcil S, Mack L, Deban M, et al
    Survival outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in selected patients with stage IV gastric adenocarcinoma - A Canadian case series.
    Eur J Surg Oncol. 2025;51:110000.
    PubMed     Abstract available
    
    
    
61. SUI W, Chen P, Chen Z, Han W, et al
    Construction of nomogram prognostic model for gastric signet ring cell carcinoma: Signet ring cell proportion influencing prognosis.
    Eur J Surg Oncol. 2025;51:110012.
    PubMed     Abstract available
    
    
    
62. WANG J, de Jongh C, Wu Z, de Groot EM, et al
    Impact of pre-treatment waiting intervals on short-term postoperative outcomes in neoadjuvant chemotherapy followed by gastrectomy: A population-based study using the Dutch Upper Gastrointestinal Cancer Audit (DUCA) data.
    Eur J Surg Oncol. 2025;51:109595.
    PubMed     Abstract available
    
    
    July 2025
63. TIAN P, Chen Z, Fang B, Wang X, et al
    Investigating the relationship between tongue diagnosis features and gastric cancer: A machine learning-based prediction model.
    Eur J Surg Oncol. 2025;51:110352.
    PubMed     Abstract available
    
    
    
64. TRIEMSTRA L, de Jongh C, Brenkman HJF, Weusten BLAM, et al
    Implementing robot-assisted minimally invasive gastrectomy (RAMIG) for gastric cancer in a European tertiary referral center.
    Eur J Surg Oncol. 2025;51:110342.
    PubMed     Abstract available
    
    
    
65. LI H
    Reply to ChatGPT-4o outperforms Gemini advanced in assisting multidisciplinary decision-making for advanced gastric cancer.
    Eur J Surg Oncol. 2025;51:110217.
    PubMed    
    
    
    
66. QIU WW, Huang ZN, Li TY, Zhang L, et al
    Comparison of short- and mid-term outcomes of robotic versus laparoscopic gastrectomy in high-risk patients with gastric cancer: a nationwide, multicentre cohort study.
    Eur J Surg Oncol. 2025;51:110294.
    PubMed     Abstract available
    
    
    
67. TAN S, Yang G
    Surgical resection for small (
    Eur J Surg Oncol. 2025;51:109998.
    PubMed     Abstract available
    
    
    June 2025
68. DENG Y, He LJ, Li X
    Robotic versus laparoscopic gastrectomy for gastric cancer in asia: A meta-analysis of short-term outcomes from six randomized controlled trials.
    Eur J Surg Oncol. 2025;51:110298.
    PubMed     Abstract available
    
    
    
69. YU D, Chen W, Zhang F, Huang H, et al
    Laparoscopic radical gastrectomy is a protective factor for clinical outcomes in gastric cancer patients with sarcopenia.
    Eur J Surg Oncol. 2025 Jun 27:110299. doi: 10.1016/j.ejso.2025.110299.
    PubMed     Abstract available
    
    
    
70. SHEIKH MI, Shahzad UB, Ahmed M
    Prognostic implications of signet ring cell proportion in gastric cancer: Insights from a novel nomogram and biomarker analysis.
    Eur J Surg Oncol. 2025;51:110245.
    PubMed    
    
    
    
71. WANG SL, Chen CB, Huang YS, Ruan XJ, et al
    Muscle-specific strength is an alternative to muscle mass and grip strength for predicting outcomes in patients with gastric cancer.
    Eur J Surg Oncol. 2025;51:110229.
    PubMed     Abstract available
    
    
    
72. CHENG Y, Tian Z, Zhou J, Zhao S, et al
    Evaluation of combined tubular gastroesophageal anastomosis and C-shaped flap technique in proximal gastrectomy for gastric cancer: A retrospective propensity score matching analysis.
    Eur J Surg Oncol. 2025;51:110227.
    PubMed     Abstract available
    
    
    
73. DAUNGSUPAWONG H, Wiwanitkit V
    RE: ChatGPT-4o outperforms gemini advanced in assisting multidisciplinary decision-making for advanced gastric cancer.
    Eur J Surg Oncol. 2025;51:110218.
    PubMed    
    
    
    
74. MARIANI A, Triantafyllou E, Kepenekian V, Zaanan A, et al
    Management of peritoneal gastric metastasis: An update.
    Eur J Surg Oncol. 2025;51:109731.
    PubMed     Abstract available
    
    
    
75. JEONG JY, Yoon JK, Hwang J, Park SH, et al
    Diagnostic performance of fluorescent lymphography-guided lymph node dissection during minimally invasive gastrectomy following chemotherapy.
    Eur J Surg Oncol. 2025;51:109738.
    PubMed     Abstract available
    
    
    
76. GREGERSEN JS, Solstad TU, Achiam MP, Olsen AA, et al
    Textbook outcome and textbook oncological outcome in esophagogastric cancer surgery - A systematic scoping review.
    Eur J Surg Oncol. 2025;51:109672.
    PubMed     Abstract available
    
    
    May 2025
77. VIVIAN CHIU SW, Tsai YN, Ker CY, Chiu CC, et al
    Comment on "Lymph node metastasis prediction model for each lymph node station in gastric cancer patients".
    Eur J Surg Oncol. 2025;51:110189.
    PubMed    
    
    
    
78. KARIMI AM, Khosravi A, Masoudi N
    Re: Optimizing surgical timing following neoadjuvant therapy for gastric cancer: Insights from a multicenter retrospective analysis.
    Eur J Surg Oncol. 2025;51:110171.
    PubMed    
    
    
    
79. CHEN J, Liu F
    Reply to: Re: Optimizing surgical timing following neoadjuvant therapy for gastric cancer: Insights from a multicenter retrospective analysis.
    Eur J Surg Oncol. 2025;51:110170.
    PubMed    
    
    
    
80. YEE EJ, Stuart CM, Kim S, McCarter MD, et al
    Impact of socioeconomic determinants of health on delays to care in gastric cancer: A national cancer database analysis.
    Eur J Surg Oncol. 2025;51:110136.
    PubMed     Abstract available
    
    
    
81. AALTONEN P, Mustonen H, Puolakkainen P, Haglund C, et al
    Incidence and prognostic role of venous thromboembolism in gastric cancer: a nationwide Finnish register study.
    Eur J Surg Oncol. 2025;51:110139.
    PubMed     Abstract available
    
    
    
82. LIU Z, Yang F, Hao Y, Jiang Q, et al
    A nomogram for predicting the risk of liver metastasis in non-functional neuroendocrine neoplasms: A population-based study.
    Eur J Surg Oncol. 2025;51:109708.
    PubMed     Abstract available
    
    
    
83. CHEN Y, Zhu X, Ding S, Chen M, et al
    Minimally invasive treatment strategies for submucosal tumors of the upper gastrointestinal tract: Advances in innovative endoscopy-based therapies.
    Eur J Surg Oncol. 2025;51:109626.
    PubMed     Abstract available
    
    
    
84. BUTTERWORTH JW, Boshier PR, Mavroveli S, Reynolds JV, et al
    A proposed framework of strategies to overcome challenges to surgical quality assurance in oncology trials (SQA-Onc.).
    Eur J Surg Oncol. 2025;51:109593.
    PubMed     Abstract available
    
    
    
85. WHITE C, Jayaprakasam VS, Tenet M, Tang LH, et al
    PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinoma.
    Eur J Surg Oncol. 2025;51:109589.
    PubMed     Abstract available
    
    
    April 2025
86. TOPKAN E, Ozturk D, Selek U
    Letter to the editor: The impact of preoperative skeletal muscle mass index-defined sarcopenia on postoperative complications and survival in gastric cancer: An updated meta-analysis.
    Eur J Surg Oncol. 2025;51:110113.
    PubMed    
    
    
    
87. SHANG-GUAN ZX, Zhong Q, Zhang ZQ, Liu ZY, et al
    Surgical and oncological outcomes of laparoscopic versus open gastrectomy after neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter analysis.
    Eur J Surg Oncol. 2025;51:110060.
    PubMed     Abstract available
    
    
    
88. LI H, Huang J, Liu K, Liu J, et al
    ChatGPT-4o outperforms gemini advanced in assisting multidisciplinary decision-making for advanced gastric cancer.
    Eur J Surg Oncol. 2025;51:110096.
    PubMed     Abstract available
    
    
    
89. CHEN J, Hu K, Lu J, Pan H, et al
    Optimizing surgical timing following neoadjuvant therapy for gastric Cancer: Insights from a multicenter retrospective analysis.
    Eur J Surg Oncol. 2025;51:110063.
    PubMed     Abstract available
    
    
    
90. AMEYA KP, Sekar D
    Letter to the editor: Outcomes of intraperitoneal chemotherapy for the treatment of gastric cancer with peritoneal metastasis: A comprehensive systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:110026.
    PubMed    
    
    
    
91. CHO YS, Berlth F, Kim J, Suh YS, et al
    Clinical outcomes of robotic and laparoscopic gastrectomy using propensity score matching method: Data of 5-year period in a Korean high-volume gastric cancer center.
    Eur J Surg Oncol. 2025;51:110014.
    PubMed     Abstract available
    
    
    
92. LIU Y, Chen Y, Shu J, Zhang Z, et al
    Dual-energy CT for predicting progression-free survival of locally advanced gastric cancer after gastrectomy: Insights into tumor angiogenesis.
    Eur J Surg Oncol. 2025;51:110017.
    PubMed     Abstract available
    
    
    March 2025
93. SEDLAK K, Kubiak M, Pelc Z, Mlak R, et al
    Corrigendum to "Prime suspect or collective responsibility: Impact of specific lymph node station dissection on short- and long-term outcomes among locally advanced gastric cancer patients after neoadjuvant chemotherapy" [Eur J Surg Oncol 51 (2025) 10
    Eur J Surg Oncol. 2025 Mar 21:109975. doi: 10.1016/j.ejso.2025.109975.
    PubMed    
    
    
    
94. MATSUI R, Ohashi M, Ri M, Makuuchi R, et al
    Worse oncological impact of preoperative anemia in patients with locally advanced gastric cancer after curative gastrectomy: A retrospective cohort study.
    Eur J Surg Oncol. 2025;51:109762.
    PubMed     Abstract available
    
    
    
95. XING J, Wang Y, Cao M, Shan F, et al
    Identifying potential beneficiaries of neoadjuvant therapy in borrmann type III and IV gastric cancer: A treatment heterogeneity analysis using causal survival forests.
    Eur J Surg Oncol. 2025;51:109752.
    PubMed     Abstract available
    
    
    
96. XIE RZ, Huang ZN, Zhang XQ, Sun YQ, et al
    Long-term survival analysis after radical gastrectomy for Epstein-Barr virus-associated gastric cancer: A multicenter study.
    Eur J Surg Oncol. 2025;51:109737.
    PubMed     Abstract available
    
    
    
97. WONG E, Kamarajah SK, Dahdaleh F, Naffouje S, et al
    Adjuvant chemotherapy for node-negative gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy: A propensity score matched analysis study.
    Eur J Surg Oncol. 2025;51:109506.
    PubMed     Abstract available
    
    
    
98. MATEUSIAK L, Hakuno S, de Jonge-Muller ESM, Floru S, et al
    Fluorescent Nanobodies for enhanced guidance in digestive tumors and liver metastasis surgery.
    Eur J Surg Oncol. 2025;51:109537.
    PubMed     Abstract available
    
    
    February 2025
99. XU R, Li Y, Zhao H, Wang Z, et al
    Tumor deposits in gastric cancer cannot be regarded as metastatic lymph nodes: A single-center retrospective study.
    Eur J Surg Oncol. 2025;51:109719.
    PubMed     Abstract available
    
    
    
100. PUTILA E, Helminen O, Helmio M, Huhta H, et al
     Preoperative predictors of postoperative complications after gastrectomy for gastric cancer, a population-based study in Finland.
     Eur J Surg Oncol. 2025;51:109682.
     PubMed     Abstract available
     
     
     
101. BACOEUR-OUZILLOU O, Voron T, Lambert C, Fuks D, et al
     Impact of obesity on outcomes following surgery for gastric adenocarcinoma: A European multi-institutional study.
     Eur J Surg Oncol. 2025;51:109518.
     PubMed     Abstract available
     
     
     
102. TIAN Z, Cheng Y, Wang Y, Ren J, et al
     A 3-Arm case-matched analysis of anti-reflux reconstruction methods after laparoscopic proximal gastrectomy - Single tract jejunal interposition vs double tract reconstruction vs tube-like stomach reconstruction.
     Eur J Surg Oncol. 2025;51:109482.
     PubMed     Abstract available
     
     
     
103. OGAWA R, Yoshikawa T, Fujisaki Y, Nishino M, et al
     Risk factors for postoperative liver dysfunction in robot-assisted gastrectomy for gastric cancer.
     Eur J Surg Oncol. 2025;51:109668.
     PubMed     Abstract available
     
     
     January 2025
104. VAN DER LINDE M, Visser MR, Eijkenaar F, Oude Voshaar MAH, et al
     Case-mix adjustment for between-hospital comparisons in oesophageal and gastric cancer surgery.
     Eur J Surg Oncol. 2025;51:109644.
     PubMed     Abstract available
     
     
     
105. SEO WJ, Kim DW, Lee CM, Park JY, et al
     Intraperitoneal paclitaxel with systemic S-1 plus oxaliplatin for advanced or recurrent gastric cancer with peritoneal metastasis: A single-arm, multicenter phase II clinical trial.
     Eur J Surg Oncol. 2025;51:109603.
     PubMed     Abstract available
     
     
     
106. KIM JW, Hong H, Park SH, Choi JH, et al
     Lymph node metastasis prediction model for each lymph node station in gastric cancer patients.
     Eur J Surg Oncol. 2025 Jan 10:109590. doi: 10.1016/j.ejso.2025.109590.
     PubMed     Abstract available
     
     
     
107. JOREK N, Weber MC, Kasajima A, Reischl S, et al
     Configuration of anastomotic doughnuts of stapled anastomoses in upper gastrointestinal surgery is associated with anastomotic leakage.
     Eur J Surg Oncol. 2025;51:109460.
     PubMed     Abstract available
     
     
     
108. LIU G, Cao S, Liu X, Tian Y, et al
     Short- and long-term outcomes following perioperative ERAS management in patients undergoing minimally invasive radical gastrectomy after neoadjuvant chemotherapy: A single-center retrospective propensity score matching study.
     Eur J Surg Oncol. 2025;51:109459.
     PubMed     Abstract available
     
     
     December 2024
109. LIU C, Li Y, Xu Y, Hou H, et al
     The impact of preoperative skeletal muscle mass index-defined sarcopenia on postoperative complications and survival in gastric cancer: An updated meta-analysis.
     Eur J Surg Oncol. 2024 Dec 28:109569. doi: 10.1016/j.ejso.2024.109569.
     PubMed     Abstract available
     
     
     
110. SUN Y, Tian Y, Li Z, Cao S, et al
     Multimodal prehabilitation to improve functional abilities and reduce the chronic inflammatory response of frail elderly patients with gastric cancer: A prospective cohort study.
     Eur J Surg Oncol. 2024;51:109563.
     PubMed     Abstract available
     
     
     
111. SEDLAK K, Kubiak M, Pelc Z, Mlak R, et al
     Prime suspect or collective responsibility: Impact of specific lymph node station dissection on short- and long-term outcomes among locally advanced gastric cancer patients after neoadjuvant chemotherapy.
     Eur J Surg Oncol. 2024;51:109545.
     PubMed     Abstract available
     
     
     
112. SUN X, Li X, Zhao S, Li C, et al
     Which surrogate endpoint best predict survival in locally advanced gastric cancer patients undergoing neoadjuvant chemoimmunotherapy followed by surgery? A multicenter retrospective study.
     Eur J Surg Oncol. 2024;51:109517.
     PubMed     Abstract available
     
     
     
113. WANG J, Wu Z, Freund JE, de Groot EM, et al
     Comparison between AJCC 8th edition gastric and esophageal ypTNM classification system in Siewert II esophagogastric junction adenocarcinomas: A retrospective study based on Eastern and Western Data.
     Eur J Surg Oncol. 2024;50:108730.
     PubMed     Abstract available
     
     
     
114. EDHOLM D, Linder G, Hedberg J, Rouvelas I, et al
     Perioperative blood transfusions associated with reduced survival in gastroesophageal cancers - A Swedish population-based study.
     Eur J Surg Oncol. 2024;50:108690.
     PubMed     Abstract available
     
     
     
115. DAYANAMBY A, Chmelo J, Bradshaw A, Phillips AW, et al
     Predictors of early recurrence of oesophagogastric adenocarcinoma after neoadjuvant FLOT.
     Eur J Surg Oncol. 2024;50:108657.
     PubMed     Abstract available
     
     
     November 2024
116. WU J, Huang ZN, Zhang XQ, Hou SS, et al
     Development of a modified nutritional index model based on nutritional status and sarcopenia to predict long-term survival and chemotherapy benefits in elderly patients with advanced gastric cancer.
     Eur J Surg Oncol. 2024;51:109503.
     PubMed     Abstract available
     
     
     
117. BOSHIER PR, Tekkis N, Baggaley A, Robb HD, et al
     Outcomes of intraperitoneal chemotherapy for the treatment of gastric cancer with peritoneal metastasis: A comprehensive systematic review and meta-analysis.
     Eur J Surg Oncol. 2024;51:109499.
     PubMed     Abstract available
     
     
     
118. DAT TQ, Thong DQ, Nguyen DT, Hai NV, et al
     Effectiveness of conversion surgery in stage IV gastric cancer.
     Eur J Surg Oncol. 2024;51:109485.
     PubMed     Abstract available
     
     
     
119. HAN L, Zhou Y, Wang Y, Chen H, et al
     Nutritional status of early oral feeding for gastric cancer patients after laparoscopic total gastrectomy: A retrospective cohort study.
     Eur J Surg Oncol. 2024 Nov 12:109379. doi: 10.1016/j.ejso.2024.109379.
     PubMed     Abstract available
     
     
     
120. HE CH, Li ZZ, Ke HW, Zhai WB, et al
     Stair climbing outperforms gait speed in predicting postoperative outcomes in patients undergoing radical gastrectomy for gastric cancer: A prospective study.
     Eur J Surg Oncol. 2024;51:109378.
     PubMed     Abstract available
     
     
     October 2024
121. BHUTIANI N, Seo YD, Robinson KA, White MG, et al
     HIPEC for metastatic gastric cancer: Moving the needle towards 3-year survival.
     Eur J Surg Oncol. 2024;51:108790.
     PubMed     Abstract available
     
     
     
122. KONDO H, Sato S, Kunisaki C, Tanaka Y, et al
     Prognostic factors in patients with pathological T3N0M0 gastric cancer: A multi-institutional, retrospective study (YCOG2202).
     Eur J Surg Oncol. 2024 Oct 23:108782. doi: 10.1016/j.ejso.2024.108782.
     PubMed     Abstract available
     
     
     
123. ZHAO B, Bao L, Zhang T, Chen Y, et al
     Prevalence of sarcopenic obesity in patients with gastric cancer and effects on adverse outcomes: A meta-analysis and systematic review.
     Eur J Surg Oncol. 2024;50:108772.
     PubMed     Abstract available
     
     
     
124. FUJISAKI YY, Yoshikawa T, Ogawa R, Nishino M, et al
     Necessity of splenectomy for antral-type scirrhous gastric cancer.
     Eur J Surg Oncol. 2024 Oct 6:108734. doi: 10.1016/j.ejso.2024.108734.
     PubMed     Abstract available
     
     
     September 2024
125. NAGATA H, Kinoshita T, Komatsu M, Habu T, et al
     Comparison of robotic versus laparoscopic total gastrectomy for gastric cancer: A single-center retrospective cohort study in a Japanese high-volume center.
     Eur J Surg Oncol. 2024;50:108706.
     PubMed     Abstract available
     
     
     
126. ZHENG H, Zheng H, Wei L, Xue Z, et al
     Risk stratification models incorporating oxidative stress factors to predict survival and recurrence in patients with gastric cancer after radical gastrectomy: A real-world multicenter study.
     Eur J Surg Oncol. 2024;50:108658.
     PubMed     Abstract available
     
     
     
127. VAN DER BURG SJ, Bleckman RF, van der Sluis PC, Hartgrink HH, et al
     Improvement of perioperative outcomes of gastric gastrointestinal stromal tumour (GIST) resections and the influence of minimal invasive surgery.
     Eur J Surg Oncol. 2024;50:108479.
     PubMed     Abstract available
     
     
     
128. DUMONT F, Kepenekian V, Passot C, Ezanno-Manasterski AC, et al
     PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial.
     Eur J Surg Oncol. 2024;50:108468.
     PubMed     Abstract available
     
     
     
129. HUANG Z, Huang Y, Huang C, Li P, et al
     Reply to: Chemotherapy benefits in patients with hepatoid adenocarcinoma: A long-term follow-up study on a rare gastric disease.
     Eur J Surg Oncol. 2024;50:108407.
     PubMed    
     
     
     August 2024
130. TAKAHASHI K, Terashima M, Notsu A, Koseki Y, et al
     Surgical treatment for liver metastasis from gastric cancer: A systematic review and meta-analysis of long-term outcomes and prognostic factors.
     Eur J Surg Oncol. 2024;50:108582.
     PubMed     Abstract available
     
     
     
131. WEI S, Yu S
     Reevaluating surgical margins in gastric cancer: Addressing the impact of close resection margins and BMI classification on prognosis.
     Eur J Surg Oncol. 2024 Aug 6:108574. doi: 10.1016/j.ejso.2024.108574.
     PubMed    
     
     
     
132. PARK JY, Park KB, Kwon OK
     Reply to: Reevaluating surgical margins in gastric cancer: Addressing the impact of close resection margins and BMI classification on prognosis.
     Eur J Surg Oncol. 2024 Aug 3:108575. doi: 10.1016/j.ejso.2024.108575.
     PubMed    
     
     
     
133. WANG SL, Zhang FM, Chen CB, Dong QT, et al
     Comparison between AWGC-cachexia and GLIM-malnutrition in patients with gastric cancer.
     Eur J Surg Oncol. 2024;50:108580.
     PubMed     Abstract available
     
     
     
134. VAN DER SLUIS K, Vollebergh MA, Kodach LL, van Dieren JM, et al
     The clinical implications of staging laparoscopy in the diagnostic workup of gastric cancer patients: A population based study.
     Eur J Surg Oncol. 2024;50:108569.
     PubMed     Abstract available
     
     
     July 2024
135. ITAMI T, Kurokawa Y, Yoshioka R, Saito T, et al
     Measuring serum and drainage fluid interleukin-6 and tumor necrosis factor-alpha levels for early detection of infectious complications after minimally invasive surgery for gastric cancer.
     Eur J Surg Oncol. 2024;50:108564.
     PubMed     Abstract available
     
     
     
136. HERRERA KOK JH, Marano L, van den Berg JW, Shetty P, et al
     Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative).
     Eur J Surg Oncol. 2024;50:108387.
     PubMed     Abstract available
     
     
     
137. ALEMDAR A, Duman MG, Sengiz Erhan S, Sasako M, et al
     Histopathologic response in patients with curative resection with D2 dissection following neoadjuvant treatment for locally advanced gastric and esophagogastric junction adenocarcinoma.
     Eur J Surg Oncol. 2024;50:108428.
     PubMed     Abstract available
     
     
     June 2024
138. PARK JY, Yang JY, Park KB, Kwon OK, et al
     Prognostic effect of microscopically negative but close resection margin in gastric cancer.
     Eur J Surg Oncol. 2024;50:108517.
     PubMed     Abstract available
     
     
     
139. AAMIR N, Waqar SA
     Letter to the editor 'Staging laparoscopy with peritoneal lavage to identify peritoneal metastases and free intraperitoneal cancer cells in the management of locally advanced gastric cancer'.
     Eur J Surg Oncol. 2024;50:108466.
     PubMed    
     
     
     
140. CHAI Y, Lin B, Zhong J, Wu X, et al
     Long-term outcomes of endoscopic therapy versus surgical resection for 2-5 cm gastric gastrointestinal stromal tumors: A population-based comparative study.
     Eur J Surg Oncol. 2024;50:108262.
     PubMed     Abstract available
     
     
     May 2024
141. MANSOOR M, Ahmed M, Manzoor I
     "Shaping gastric cancer outcomes: Advancing diagnosis and treatment through staging laparoscopy in peritoneal Metastasis detection".
     Eur J Surg Oncol. 2024;50:108448.
     PubMed    
     
     
     April 2024
142. ZHANG LK, Zheng HL, Zheng HH, Ma YB, et al
     Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy.
     Eur J Surg Oncol. 2024;50:108367.
     PubMed     Abstract available
     
     
     
143. BELIA F, Kim KY, Agnes A, Park SH, et al
     Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database.
     Eur J Surg Oncol. 2024;50:108359.
     PubMed     Abstract available
     
     
     
144. BHANDARE MS, Gundavda KK, Yelamanchi R, Chopde A, et al
     Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: Analysis of 1001 cases.
     Eur J Surg Oncol. 2024;50:108343.
     PubMed     Abstract available
     
     
     
145. COSTA PMD, Antunes C, Lages P, Rodrigues J, et al
     Challenging the Dogma: Stage migration or negative lymph nodes, which of them is the main player on gastric cancer prognosis?
     Eur J Surg Oncol. 2024;50:108318.
     PubMed     Abstract available
     
     
     
146. SHEEN AR, Saqib HWU
     "Harnessing AI for treatment optimization: Neoadjuvant chemotherapy in gastroesophageal cancer".
     Eur J Surg Oncol. 2024;50:108228.
     PubMed    
     
     
     
147. KUHLEN M, Kunstreich M, Pape UF, Seitz G, et al
     Lymph node metastases are more frequent in paediatric appendiceal NET >/=1.5 cm but without impact on outcome - Data from the German MET studies.
     Eur J Surg Oncol. 2024;50:108051.
     PubMed     Abstract available
     
     
     
148. VAN HOOTEGEM SJM, Chmelo J, van der Sluis PC, Lagarde SM, et al
     The yield of diagnostic laparoscopy with peritoneal lavage in gastric adenocarcinoma: A retrospective cohort study.
     Eur J Surg Oncol. 2024;50:108233.
     PubMed     Abstract available
     
     
     
149. MAURER CA, Walensi M, Mattiello D, Kaser SA, et al
     Intraoperative esophageal washout reduces free intraluminal tumor cells during resection of carcinomas of the esophagus and cardia.
     Eur J Surg Oncol. 2024;50:108017.
     PubMed     Abstract available
     
     
     March 2024
150. HUANG ZN, Zheng CY, Wu J, Tang YH, et al
     Textbook oncological outcomes and prognosis after curative gastrectomy in advanced gastric cancer: A multicenter study.
     Eur J Surg Oncol. 2024;50:108280.
     PubMed     Abstract available
     
     
     
151. VAN DER SLUIS K, Guchelaar NAD, Triemstra L, Mathijssen RHJ, et al
     Staging laparoscopy in gastric cancer patients: From a Dutch nationwide Delphi consensus towards a standardized protocol.
     Eur J Surg Oncol. 2024;50:108278.
     PubMed     Abstract available
     
     
     
152. HUANG B, Rampulla V, Ri M, Lindblad M, et al
     Staging laparoscopy with peritoneal lavage to identify peritoneal metastases and free intraperitoneal cancer cells in the management of locally advanced gastric cancer.
     Eur J Surg Oncol. 2024;50:108059.
     PubMed     Abstract available
     
     
     
153. LIN X, Tan C, Wu W, Liang C, et al
     Evaluation of factors influencing long-term and textbook outcomes in laparoscopic gastrectomy.
     Eur J Surg Oncol. 2024;50:108002.
     PubMed     Abstract available
     
     
     February 2024
154. NOOR Z, Gossage J, Evans O, Cuffe R, et al
     Unmet needs in survivorship: Increased anxiety post oesophago-gastric cancer surgery.
     Eur J Surg Oncol. 2024;50:108046.
     PubMed     Abstract available
     
     
     
155. LI J, Chen X, Xu S, Wang Y, et al
     Predicting pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer: The establishment of a spectral CT-based nomogram from prospective datasets.
     Eur J Surg Oncol. 2024;50:108020.
     PubMed     Abstract available
     
     
     
156. ZHENG HL, Wei LH, Xu BB, Zheng HH, et al
     Prognostic value of preoperative sarcopenia in gastric cancer: A 10-year follow-up study.
     Eur J Surg Oncol. 2024;50:108004.
     PubMed     Abstract available
     
     
     January 2024
157. TAKI Y, Ito S, Mizusawa J, Yura M, et al
     Risk factors for abdominal surgical infectious complications after distal gastrectomy for gastric cancer: A post-hoc analysis of a randomized controlled trial (JCOG0912).
     Eur J Surg Oncol. 2024;50:107982.
     PubMed     Abstract available
     
     
     December 2023
158. MIAO X, Guo Y, Chen Y, Xu X, et al
     Exploration of frailty trajectories and their associations with health outcomes in older gastric cancer survivors undergoing radical gastrectomy: A prospective longitudinal observation study.
     Eur J Surg Oncol. 2023;50:107934.
     PubMed     Abstract available
     
     
     
159. YAO GL, Tao YJ, Fan YG
     Cutaneous metastasis from gastric cancer: Manifestation, diagnosis, treatment and prognosis.
     Eur J Surg Oncol. 2023;50:107939.
     PubMed     Abstract available
     
     
     
160. MENG C, Cao S, Yu Q, Tian Y, et al
     Short- and long-term comparison of robotic versus laparoscopic gastrectomy for gastric cancer patients with BMI>/=30 kg/m(2): A propensity score matched analysis.
     Eur J Surg Oncol. 2023;50:107312.
     PubMed     Abstract available
     
     
     
161. HOJO Y, Ishida Y, Tomita T, Kurahashi Y, et al
     Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer.
     Eur J Surg Oncol. 2023;50:107314.
     PubMed     Abstract available
     
     
     
162. TRIEMSTRA L, de Jongh C, Tedone F, Brosens LAA, et al
     The Comprehensive Complication Index versus Clavien-Dindo grading after laparoscopic and open D2-gastrectomy in the multicenter randomized LOGICA-trial.
     Eur J Surg Oncol. 2023;49:107095.
     PubMed     Abstract available
     
     
     November 2023
163. MINISTRINI S, Bencivenga M, Filippini F, Mura G, et al
     A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series.
     Eur J Surg Oncol. 2023;50:107275.
     PubMed     Abstract available
     
     
     
164. HOLMEN A, Jebril W, Ida S, Agustsson T, et al
     Effects of neoadjuvant therapy on health-related quality of life for patients with gastroesophageal cancer.
     Eur J Surg Oncol. 2023;49:107008.
     PubMed     Abstract available
     
     
     
165. KANG MK, Kim J, Choi JH, Choe HN, et al
     Can prospective monitoring improve complication rates after gastrectomy? Experience of Billroth I reconstruction at a high-volume tertiary center.
     Eur J Surg Oncol. 2023;49:106985.
     PubMed     Abstract available
     
     
     
166. HUANG ZN, Huang YQ, Hong QQ, Zhang P, et al
     Long-term prognostic benefit of adjuvant chemotherapy for patients with hepatoid adenocarcinoma of the stomach after radical resection: A national multicenter study.
     Eur J Surg Oncol. 2023;49:106975.
     PubMed     Abstract available
     
     
     
167. SALAVATIZADEH M, Soltanieh S, Radkhah N, Ataei Kachouei AH, et al
     The association between skeletal muscle mass index (SMI) and survival after gastrectomy: A systematic review and meta-analysis of cohort studies.
     Eur J Surg Oncol. 2023;49:106980.
     PubMed     Abstract available
     
     
     October 2023
168. ZHANG J, Cao X, Dai N, Zhu S, et al
     Efficacy analysis of endoscopic treatment of giant gastric gastrointestinal stromal tumors (>/=5 cm).
     Eur J Surg Oncol. 2023;49:106955.
     PubMed     Abstract available
     
     
     
169. WITHEY SJ, Owczarczyk K, Grzeda MT, Yip C, et al
     Association of dynamic contrast-enhanced MRI and (18)F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer.
     Eur J Surg Oncol. 2023;49:106934.
     PubMed     Abstract available
     
     
     
170. VISSERS PAJ, Luijten JCHBM, Lemmens VEPP, van Laarhoven HWM, et al
     The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival.
     Eur J Surg Oncol. 2023;49:107019.
     PubMed     Abstract available
     
     
     
171. ELSHAER AM, Wijeyaratne M, Higgs SM, Hornby ST, et al
     Peri-operative chemotherapy versus preoperative chemoradiotherapy in treatment of gastro-oesophageal junctional adenocarcinomas: A 10-year cohort study.
     Eur J Surg Oncol. 2023;49:107016.
     PubMed     Abstract available
     
     
     September 2023
172. ZHENG CY, Wu J, Chen CS, Huang ZN, et al
     A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter study.
     Eur J Surg Oncol. 2023;49:107094.
     PubMed     Abstract available
     
     
     
173. ZHOU M, Zhong G, Sun H, Zhu Q, et al
     Risk factors for postoperative pancreatic fistula (POPF) in gastric cancer patients: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2023;49:107092.
     PubMed     Abstract available
     
     
     
174. REIS ME, Ulusahin M, Cekic AB, Usta MA, et al
     Does surgeon specialization add value to surgeon volume in gastric cancer surgery?
     Eur J Surg Oncol. 2023;49:107091.
     PubMed     Abstract available
     
     
     
175. IKEGAME K, Hatakeyama K, Terashima M, Sugino T, et al
     Molecular profiling of gastric neuroendocrine carcinomas.
     Eur J Surg Oncol. 2023;49:106987.
     PubMed     Abstract available
     
     
     
176. LUIJTEN JCHBM, Vissers PAJ, Geerts J, Lemmens VEP, et al
     Hospital practice variation in the proportion of patients with esophagogastric cancer discussed during an expert multidisciplinary team meeting.
     Eur J Surg Oncol. 2023;49:106880.
     PubMed     Abstract available
     
     
     
177. LIN X, Tan C, Li Z, Wu W, et al
     Long-term oncologic and surgical outcomes of robotic and laparoscopic gastrectomy for Siewert II/III esophagogastric junction carcinoma: A propensity score-matched retrospective cohort study.
     Eur J Surg Oncol. 2023;49:106898.
     PubMed     Abstract available
     
     
     
178. FUNK-DEBLEDS P, Rossi J, Bernard L, Galan A, et al
     Post-operative weight loss affects 3-year survival in patients with gastric adenocarcinoma after gastrectomy and hyperthermic intraperitoneal chemotherapy.
     Eur J Surg Oncol. 2023;49:106895.
     PubMed     Abstract available
     
     
     August 2023
179. DE JONGH C, Triemstra L, van der Veen A, Brosens LA, et al
     Surgical quality and prospective quality control of the D2-gastrectomy for gastric cancer in the multicenter randomized LOGICA-trial.
     Eur J Surg Oncol. 2023;49:107018.
     PubMed     Abstract available
     
     
     June 2023
180. BIONDI A, Lorenzon L, Santoro G, Agnes A, et al
     Profiling complete regression after pre-operative therapy in gastric cancer patients using clinical and pathological data.
     Eur J Surg Oncol. 2023 Jun 30:S0748-7983(23)00561.
     PubMed     Abstract available
     
     
     March 2023
181. HERRERA-KOK JH, Parmar C, Bangash AH, Samadov E, et al
     Global impact of COVID-19 pandemic on gastric cancer patients.
     Eur J Surg Oncol. 2023 Mar 2:S0748-7983(23)00170.
     PubMed    
     
     
     January 2023
182. ZHENG HL, Lin J, Shen LL, Yang HB, et al
     The GLIM criteria as an effective tool for survival prediction in gastric cancer patients.
     Eur J Surg Oncol. 2023 Jan 12:S0748-7983(23)00031.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum